McKaylee M Robertson
Overview
Explore the profile of McKaylee M Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Penrose K, Srivastava A, Shen Y, Robertson M, Kulkarni S, Allen K, et al.
Infect Dis Ther
. 2024 Jun;
13(8):1743-1757.
PMID: 38909338
Introduction: Oral antiviral medications are important tools for preventing severe COVID-19 outcomes. However, their uptake remains low for reasons that are not entirely understood. Our study aimed to assess the...
2.
Shen Y, Robertson M, Kulkarni S, Puzniak L, Zamparo J, Allen K, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofad674.
PMID: 38344131
Background: We described the oral nirmatrelvir/ritonavir (NMV/r) and molnupiravir (MOV) uptake among a subgroup of highly vaccinated adults in a US national prospective cohort who were infected with severe acute...
3.
Nash D, Srivastava A, Shen Y, Penrose K, Kulkarni S, Zimba R, et al.
Sci Rep
. 2024 Jan;
14(1):644.
PMID: 38182731
This study used repeat serologic testing to estimate infection rates and risk factors in two overlapping cohorts of SARS-CoV-2 N protein seronegative U.S. adults. One mostly unvaccinated sub-cohort was tracked...
4.
Nash D, Srivastava A, Shen J, Penrose K, Kulkarni S, Zimba R, et al.
medRxiv
. 2023 Oct;
PMID: 37873066
Background: Infectious disease surveillance systems, which largely rely on diagnosed cases, underestimate the true incidence of SARS-CoV-2 infection, due to under-ascertainment and underreporting. We used repeat serologic testing to measure...
5.
Qasmieh S, Robertson M, Nash D
Health Secur
. 2023 Aug;
21(S1):S47-S55.
PMID: 37643313
No abstract available.
6.
Irvine M, Abdelqader F, Levin B, Thomas J, Avoundjian T, Peterson M, et al.
BMJ Open
. 2023 Jul;
13(7):e076716.
PMID: 37451738
Introduction: With progress in the 'diagnose', 'link' and 'retain' stages of the HIV care continuum, viral suppression (VS) gains increasingly hinge on antiretroviral adherence among people with HIV (PWH) retained...
7.
Qasmieh S, Robertson M, Teasdale C, Kulkarni S, Jones H, Larsen D, et al.
Commun Med (Lond)
. 2023 Jun;
3(1):92.
PMID: 37391483
Background: Routine case surveillance data for SARS-CoV-2 are incomplete, unrepresentative, missing key variables of interest, and may be increasingly unreliable for timely surge detection and understanding the true burden of...
8.
Qasmieh S, Robertson M, Teasdale C, Kulkarni S, Jones H, McNairy M, et al.
Prev Med
. 2023 Feb;
169:107461.
PMID: 36813250
Due to changes in SARS-CoV-2 testing practices, passive case-based surveillance may be an increasingly unreliable indicator for monitoring the burden of SARS-CoV-2, especially during surges. We conducted a cross-sectional survey...
9.
Rane M, Robertson M, Kulkarni S, Frogel D, Gainus C, Nash D
Vaccine
. 2023 Jan;
41(4):989-998.
PMID: 36588007
Background: It is critical to monitor changes in vaccine effectiveness against COVID-19 outcomes for various vaccine products in different population subgroups. Methods: We conducted a retrospective study in patients ≥12 ...
10.
Robertson M, Qasmieh S, Kulkarni S, Teasdale C, Jones H, McNairy M, et al.
Clin Infect Dis
. 2022 Dec;
76(9):1636-1645.
PMID: 36542514
Background: We estimated the prevalence of long COVID and impact on daily living among a representative sample of adults in the United States. Methods: We conducted a population-representative survey, 30...